trovafloxacin has been researched along with Gonorrhea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, L; Garcia-Mendez, E; Jiménez De Anta, MT; Marco, F; Mensa, J; Ruiz, J; Sierra, JM; Vila, J | 1 |
| Kluytmans, JA; Stolz, E; van Rijsoort-Vos, JH; Verbrugh, HA | 1 |
| Blalock, CJ; Hook, EW; Johnson, RB; Pinson, GB | 1 |
| Dalu, ZA; Johnson, RB; Jones, RB; Leone, P; Schwebke, J; Thorpe, EM | 1 |
| Provenzano, SL | 1 |
| Kanayama, A; Kobayashi, I; Mochida, O; Naito, S; Saika, T; Tanaka, M; Tunoe, H | 1 |
2 trial(s) available for trovafloxacin and Gonorrhea
| Article | Year |
|---|---|
Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Naphthyridines; Neisseria gonorrhoeae | 1996 |
Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group.
Topics: Adolescent; Adult; Anti-Infective Agents; Double-Blind Method; Female; Fluoroquinolones; Gonorrhea; Humans; Male; Naphthyridines; Neisseria gonorrhoeae; Ofloxacin; Treatment Outcome; Urethritis; Uterine Cervicitis | 1998 |
4 other study(ies) available for trovafloxacin and Gonorrhea
| Article | Year |
|---|---|
In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Genes, Bacterial; Gonorrhea; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Nalidixic Acid; Naphthyridines; Neisseria gonorrhoeae; Ofloxacin; Quinolines | 2003 |
In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Fluoroquinolones; Gonorrhea; Humans; Microbial Sensitivity Tests; Naphthyridines; Neisseria gonorrhoeae; Pefloxacin; Penicillins | 1995 |
[Trovafloxacin in gynecology].
Topics: Anti-Infective Agents; Chlamydia Infections; Female; Fluoroquinolones; Genital Diseases, Female; Gonorrhea; Humans; Naphthyridines; Vaginosis, Bacterial | 1999 |
Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Gonorrhea; Humans; Levofloxacin; Naphthyridines; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin | 2000 |